US2011142987A1PendingUtilityA1
Use of proline specific endoproteases to hydrolyse peptides and proteins
Est. expirySep 23, 2023(expired)· nominal 20-yr term from priority
A61P 9/00A61P 5/14A61P 37/06A61P 25/24A61P 3/10A61P 3/02A61P 25/18A61P 1/14A61P 1/12A61P 19/04A61P 1/16C12P 21/06A61K 38/482A23J 3/346
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a process for the proteolytic hydrolysis of a peptide or a polypeptide, said peptide or polypeptide comprising 4 to 40, preferably 5 to 35, amino acid residues and said peptide or polypeptide is not hydrolysable by subtilisin whereby said peptide or polypeptide is hydrolysed by a proline specific endo protease at a pH of 6.5 or lower, preferably 5.5 or lower and more preferably 5.0 or lower to hydrolyse said peptide or polypeptide.
Claims
exact text as granted — not AI-modified1 - 19 . (canceled)
20 . Use of a proline specific endoprotease to produce food which is devoid of celiac related epitopes.
21 . Use according to claim 19 wherein the celiac related epitopes are gluten epitopes.
22 . Use according to claim 21 wherein the gluten epitopes are wheat or barley epitopes.
23 . Use according to claim 20 wherein the food is beer.
24 . Use according to claim 23 whereby the proline specific endoprotease is added after the mashing and before the fermentation step in the beer brewing process.
25 . Use according to claim 20 wherein the food is bread.
26 . Use according to claim 20 whereby the proline specific endoprotease is an Aspergillus, preferably an Aspergillus niger enzyme.
27 . Process for the production of food which is devoid of celiac related epitopes comprising the use of a proline specific endoprotease.
28 . Process according to claim 27 wherein proline specific endoprotease is used at low pH to reduce the level of cereal derived toxic, proline rich peptides.
29 . Beer obtainable by the use of claim 23 that is safe for people suffering from celiac disease.
30 . Bread obtainable by the use of claim 25 that is safe for people suffering from celiac disease.Join the waitlist — get patent alerts
Track US2011142987A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.